BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26935355)

  • 1. Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality.
    Strömberg U; Peterson S; Holmberg E; Holmén A; Persson B; Sandberg C; Nilbert M
    Acta Oncol; 2016 Aug; 55(8):993-1000. PubMed ID: 26935355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
    Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
    Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
    Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
    Eriksson H; Lyth J; Andersson TM
    Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
    Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
    J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
    Lyth J; Carstensen J; Synnerstad I; Lindholm C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial disparities in melanoma incidence and prognosis with consideration to stage at diagnosis, gender and marital status.
    Strömberg U; Holmén A; Peterson S
    Spat Spatiotemporal Epidemiol; 2016 Nov; 19():21-27. PubMed ID: 27839577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
    Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
    Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease mapping of early- and late-stage cancer to monitor inequalities in early detection: a study of cutaneous malignant melanoma.
    Strömberg U; Parkes BL; Holmén A; Peterson S; Holmberg E; Baigi A; Piel FB
    Eur J Epidemiol; 2020 Jun; 35(6):537-547. PubMed ID: 32350689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
    Utjés D; Lyth J; Lapins J; Eriksson H
    Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada.
    Ghazawi FM; Le M; Lagacé F; Cyr J; Alghazawi N; Zubarev A; Roy SF; Rahme E; Netchiporouk E; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
    J Cutan Med Surg; 2019; 23(4):394-412. PubMed ID: 31132871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
    Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
    J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic instrument for survival outcome in melanoma patients: based on data from the population-based Swedish Melanoma Register.
    Lyth J; Mikiver R; Nielsen K; Isaksson K; Ingvar C
    Eur J Cancer; 2016 May; 59():171-178. PubMed ID: 27046697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
    Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
    Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
    Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
    Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient.
    Jones ME; Shugg D; Dwyer T; Young B; Bonett A
    Med J Aust; 1992 Sep; 157(6):373-8. PubMed ID: 1447984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.
    Eriksson H; Frohm-Nilsson M; Järås J; Kanter-Lewensohn L; Kjellman P; Månsson-Brahme E; Vassilaki I; Hansson J
    Br J Dermatol; 2015 Jan; 172(1):175-86. PubMed ID: 24910143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cutaneous melanoma in Sweden-Stage-specific survival and rate of recurrence.
    Rockberg J; Amelio JM; Taylor A; Jörgensen L; Ragnhammar P; Hansson J
    Int J Cancer; 2016 Dec; 139(12):2722-2729. PubMed ID: 27563839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
    Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.